Knome
Cambridge, Massachusetts, United States
About Knome
Knome is dedicated to the functional interpretation of the human genome, rendering sequencing data into meaningful, powerful information to fuel important progress in the identification, prevention and management of disease. Founded by a globally recognized pioneer in the genomic sequencing space and an industry leader in information technology solutions, Knome is a leading expert in the interpretation of human genomes. By automating data integration and in-depth analysis, Knome's proprietary technology platform ’ kGAP™ 2.0 ’ provides the ability to derive actionable insights from the raw data of multiple genomes in record time. Knome's offerings include KnomeDISCOVERY™ for the research community and KnomeSIGHT™ for private clients and their families.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $28.8M
- Funding stage: M&A
- Last round: Series D (Jan 2014)
- Website: knome.com
- Phone: +1 617-941-4130
Industries & Categories
Biotechnology, Genetics, Health Care, Software
Social Profiles
Canonical: https://fsome.com/organization/knome-2536212 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.